ATE390482T1 - Interleukin-1 hy2. mittel und verfahren - Google Patents

Interleukin-1 hy2. mittel und verfahren

Info

Publication number
ATE390482T1
ATE390482T1 AT00937687T AT00937687T ATE390482T1 AT E390482 T1 ATE390482 T1 AT E390482T1 AT 00937687 T AT00937687 T AT 00937687T AT 00937687 T AT00937687 T AT 00937687T AT E390482 T1 ATE390482 T1 AT E390482T1
Authority
AT
Austria
Prior art keywords
interleukin
methods
novel
nucleic acids
receptor antagonist
Prior art date
Application number
AT00937687T
Other languages
English (en)
Inventor
Dennis Ballinger
John Ford
Alice Ho
Hai Lin
Ann Pace
Original Assignee
Nuvelo Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/316,081 external-priority patent/US6339141B1/en
Application filed by Nuvelo Inc filed Critical Nuvelo Inc
Application granted granted Critical
Publication of ATE390482T1 publication Critical patent/ATE390482T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT00937687T 1999-05-20 2000-05-22 Interleukin-1 hy2. mittel und verfahren ATE390482T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/316,081 US6339141B1 (en) 1999-05-20 1999-05-20 Interleukin-1 Hy2 materials and methods
US09/522,964 US6372892B1 (en) 1999-05-20 2000-03-10 Interleukin—1 Hy2 materials and methods

Publications (1)

Publication Number Publication Date
ATE390482T1 true ATE390482T1 (de) 2008-04-15

Family

ID=26980226

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00937687T ATE390482T1 (de) 1999-05-20 2000-05-22 Interleukin-1 hy2. mittel und verfahren

Country Status (6)

Country Link
US (1) US6365726B1 (de)
EP (1) EP1179068B1 (de)
AT (1) ATE390482T1 (de)
AU (1) AU5282600A (de)
ES (1) ES2300266T3 (de)
WO (1) WO2000071719A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2395417A1 (en) * 1999-12-10 2001-06-14 Amgen Inc. Interleukin-1 receptor antagonist-related molecules and uses thereof
CA2398242A1 (en) * 2000-01-27 2001-08-02 Immunex Corporation Fil-1 theta dnas and polypeptides
JP2004517619A (ja) * 2000-12-21 2004-06-17 ノバルティス アクチエンゲゼルシャフト インターロイキン−１関連遺伝子およびタンパク質
UA78516C2 (en) * 2001-08-10 2007-04-10 Applied Research Systems Use of inhibitors of il-18 for treatment and/or prevention of hypersensitivity disorders, and in particular of delayed-type hypersensitivity
WO2006024038A2 (en) * 2004-08-27 2006-03-02 Codman & Shurtleff Light-based implant for treating alzheimer’s disease
US7288108B2 (en) * 2005-03-14 2007-10-30 Codman & Shurtleff, Inc. Red light implant for treating Parkinson's disease
USRE47266E1 (en) 2005-03-14 2019-03-05 DePuy Synthes Products, Inc. Light-based implants for treating Alzheimer's disease
WO2006128172A2 (en) * 2005-05-26 2006-11-30 Synta Pharmaceuticals Corp. Method for treating b cell regulated autoimmune disorders
US7351253B2 (en) * 2005-06-16 2008-04-01 Codman & Shurtleff, Inc. Intranasal red light probe for treating Alzheimer's disease
WO2007034465A2 (en) * 2005-09-21 2007-03-29 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Use of il-1f5 for the modulation of an immune-mediated response
US7819907B2 (en) * 2005-10-31 2010-10-26 Codman & Shurtleff, Inc. Device and method for fixing adjacent bone plates
PL2068889T3 (pl) * 2006-08-10 2020-06-29 Roy C. Levitt Anakinra do zastosowania do leczenia zespołu zarostowego zapalenia oskrzelików
US9320914B2 (en) 2008-03-03 2016-04-26 DePuy Synthes Products, Inc. Endoscopic delivery of red/NIR light to the subventricular zone
US20100198316A1 (en) * 2009-02-04 2010-08-05 Richard Toselli Intracranial Red Light Treatment Device For Chronic Pain
CN104302772B (zh) 2012-05-18 2017-11-10 爱德迪安（北京）生物技术有限公司 用于糖尿病治疗的蛋白、蛋白缀合物及其应用
EP3400962A1 (de) 2017-05-09 2018-11-14 Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. Inhibitoren von il-38 zur verwendung bei der behandlung und/oder prävention von krebs bei einem menschen
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7103198A (en) * 1997-04-21 1998-11-13 Schering Corporation Mammalian cytokines; related reagents and methods
JP2002510492A (ja) * 1998-04-03 2002-04-09 ハイセック，インコーポレーテッド インターロイキン−１レセプターアンタゴニストおよびその使用
CA2395417A1 (en) * 1999-12-10 2001-06-14 Amgen Inc. Interleukin-1 receptor antagonist-related molecules and uses thereof

Also Published As

Publication number Publication date
AU5282600A (en) 2000-12-12
WO2000071719A1 (en) 2000-11-30
US6365726B1 (en) 2002-04-02
EP1179068B1 (de) 2008-03-26
WO2000071719A8 (en) 2001-06-21
EP1179068A1 (de) 2002-02-13
ES2300266T3 (es) 2008-06-16

Similar Documents

Publication Publication Date Title
ATE390482T1 (de) Interleukin-1 hy2. mittel und verfahren
CY2014038I2 (el) Αντι-il-6 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
WO2003025148A3 (en) Novel nucleic acids and polypeptides
WO2002070539A3 (en) Novel nucleic acids and polypeptides
WO2002081731A3 (en) Novel nucleic acids and polypeptides
DK1436309T3 (da) BGL3-beta-glukosidase og nukleinsyrer kodende derfor
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
DK0966454T3 (da) Disubstituerede bicykliske heterocykler, deres fremstilling og deres anvendelse som lægemidler
WO2001075067A3 (en) Novel nucleic acids and polypeptides
WO2001066689A3 (en) Novel nucleic acids and polypeptides
WO2001088088A3 (en) Novel nucleic acids and polypeptides
WO2002059260A3 (en) Nucleic acids and polypeptides
WO2004080148A3 (en) Novel nucleic acids and polypeptides
WO2003029271A3 (en) Novel nucleic acids and polypeptides
DK1930439T3 (da) Neurotrofe faktorer
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
ATE348613T1 (de) Zolpidem hemitartrat solvat
WO2004087874A3 (en) Novel nucleic acids and polypeptides
WO2002070541A3 (en) Peptide deformylase inhibitors
DE60133366D1 (de) Irak-4 zusammensetzungen und deren verwendungen
WO2002070565A3 (en) High-affinity antagonists of elr-cxc chemokines
WO2003000893A3 (en) Nucleic acids encoding g protein-coupled receptors
EP1446419A4 (de) Therapeutische polypeptide, für diese codierende nukleinsäuren und anwendungsverfahren
WO2002044340A3 (en) Novel nucleic acids and polypeptides
WO2003025134A3 (en) mcFP ENCODING NUCLEIC ACIDS, POLYPEPTIDES, ANTIBODIES AND METHODS OF USE THEREOF

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties